The importance of the ALDH+ and CD44+CD24− cell populations in breast cancer, and the comparative lack of knowledge about cells that express either or both markers in the normal breast, highlight the importance of further characterizing these populations. This evidence concerns the gene CD44 and breast carcinoma.